Document Detail


Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions: The ORBIT I Trial.
MedLine Citation:
PMID:  23460596     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objective: The ORBIT I trial evaluated the safety and performance of an orbital atherectomy system (OAS) for the treatment of de novo calcified coronary lesions. Background: Severely calcified coronary arteries pose an ongoing treatment challenge. Stent placement in calcified lesions can result in stent under expansion, malapposition, and procedural complications. OAS treatment may change calcified lesion compliance to reduce procedural complications and facilitate stent placement. Methods: The ORBIT I trial, a prospective, nonrandomized study, was conducted in two centers in India. Fifty patients with de novo calcified coronary lesions were enrolled. Patients were treated with the OAS followed by stent placement. Results: The average age of the patients was 57.4 years and 90% were male. Mean lesion length was 13.4 mm. The average number of OAS devices used per patient was 1.3. Device success was 98%, and procedural success was 94%. The cumulative major adverse cardiac event rate was 4% in-hospital (two non-Q-wave myocardial infarctions), 6% at 30 days (one additional non-Q-wave myocardial infarction leading to target lesion revascularization), and 8% at 6 months (one additional event of cardiac death). Angiographic complications were observed in seven patients (six dissections and one perforation). Conclusion: The ORBIT I trial suggests that the OAS may offer an effective method to change compliance of calcified coronary lesions to facilitate optimal stent placement in these difficult to treat patients. A larger trial is required to establish safety and overall effectiveness of the OAS in treating calcified coronary lesions. © 2012 Wiley Periodicals, Inc.
Authors:
Keyur Parikh; Praveen Chandra; Nishit Choksi; Puneet Khanna; Jeffrey Chambers
Related Documents :
23334496 - Chronic cyanosis due to persistent left superior vena cava draining into the left atriu...
8664536 - Radiofrequency ablation of arrhythmias in the pediatric patient.
9246406 - Pitfalls and complications of left thoracoabdominal esophagectomy.
7628026 - Optimal placement of cvp catheter in paediatric cardiac patients.
22916846 - Antiarrhythmic properties of ranolazine--from bench to bedside.
1711636 - Effects of intravenous endothelin on hemodynamics and cardiac contractility in consciou...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-3-5
Journal Detail:
Title:  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions     Volume:  -     ISSN:  1522-726X     ISO Abbreviation:  Catheter Cardiovasc Interv     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-3-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100884139     Medline TA:  Catheter Cardiovasc Interv     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Wiley Periodicals, Inc.
Affiliation:
Care Institute of Medical Science, The Heart Care Clinic, Ahmedabad, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Shape mapping: genetic mapping meets geometric morphometrics.
Next Document:  Transapical transcatheter aortic valve implantation in a heart transplant recipient with severely de...